Aethlon Medical
AEMD
Aethlon Medical (AEMD) earnings history
Most recent quarter
- Fiscal period
- Q1 2027
- Period end
- Jun 30, 2026
- EPS actual
- −$4.02
- EPS estimate
- −$3.93
- EPS surprise
- −2.42%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2027 | Aug 13, 2026 | −$3.93 | −$4.02 | −2.42% | $0.00 | SEC |
| Q4 2026 | Jun 10, 2026 | −$10.83 | $20.40 | +288.40% | $0.00 | SEC |
| Q3 2026 | Feb 12, 2026 | −$13.75 | −$12.25 | +10.91% | $0.00 | SEC |
| Q2 2026 | Nov 12, 2025 | −$18.32 | −$18.70 | −2.09% | $0.00 | SEC |
| Q1 2026 | Aug 13, 2025 | −$43.05 | −$42.50 | +1.27% | $0.00 | SEC |
| Q4 2025 | Jun 26, 2025 | −$53.67 | −$161.00 | −200.00% | $0.00 | SEC |
| Q3 2025 | Feb 12, 2025 | −$81.33 | −$52.00 | +36.07% | $0.00 | SEC |
| Q2 2025 | Nov 13, 2024 | −$78.00 | −$80.00 | −2.56% | $0.00 | SEC |
| Q1 2025 | Aug 14, 2024 | −$126.00 | −$136.00 | −7.94% | $0.00 | SEC |
| Q4 2024 | Jun 27, 2024 | −$492.00 | −$348.00 | +29.27% | $0.00 | SEC |
| Q3 2024 | Feb 14, 2024 | −$540.00 | −$548.00 | −1.48% | $0.00 | SEC |
| Q2 2024 | Nov 14, 2023 | −$560.00 | −$488.00 | +12.86% | $0.00 | SEC |
| Q1 2024 | Aug 10, 2023 | −$520.00 | −$560.00 | −7.69% | $0.00 | SEC |
| Q4 2023 | Jun 28, 2023 | −$580.00 | −$400.00 | +31.03% | $574,200.00 | SEC |
| Q3 2023 | Feb 13, 2023 | −$320.00 | −$480.00 | −50.00% | $0.00 | SEC |
| Q2 2023 | Nov 14, 2022 | −$746.67 | −$720.00 | +3.57% | $574,000.00 | — |
| Q1 2023 | Aug 9, 2022 | −$880.00 | −$760.00 | +13.64% | $0.00 | — |
| Q4 2022 | Jun 28, 2022 | −$560.00 | −$1,040.00 | −85.71% | $13,050.00 | — |
| Q3 2022 | Feb 14, 2022 | −$560.00 | −$640.00 | −14.29% | $17,117.00 | — |
| Q2 2022 | Nov 9, 2021 | −$600.00 | −$520.00 | +13.33% | $132,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Aethlon Medical (AEMD) last report earnings?
Aethlon Medical last reported on Aug 13, 2026, covering fiscal Q1 2027.
Did AEMD beat earnings estimates?
No. Aethlon Medical reported EPS of −$4.02 for Q1 2027 against a −$3.93 estimate — a 2.42% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.